Reversal of clonidine-induced hypotension by beta-adrenoceptor blocking drugs

European Journal of Pharmacology
H L Garvey, B L Woodhouse

Abstract

The interaction between clonidine, propranolol and sotalol was investigated using conscious normotensive and spontaneously hypertensive rabbits as well as conscious normotensive and spontaneously hypertensive rats. Clonidine (20 micrograms/kg) administration into the marginal ear vein of rabbits produced persistent hypotension and bradycardia. In propranolol (0.5 mg/kg, i.v.)-pretreated animals, clonidine-induced hypotension was prevented. In rats, daily oral or subcutaneous clonidine as well as propranolol produced hypotension and bradycardia. Significant antagonism of the observed hypotensive effects resulted when clonidine was given to propranolol-pretreated animals or when propranolol was added to the treatment regimen of animals being maintained on clonidine. No antagonism between sotalol and clonidine was demonstrable. In view of the known central site of action of clonidine, and the failure of sotalol to antagonize clonidine-induced hypotension it would appear that the central nervous system is a possible site of the observed drug interaction.

References

Mar 1, 1975·The Journal of Pharmacy and Pharmacology·L FinchT J Bucher
Sep 1, 1975·European Journal of Pharmacology·H L Garvey, N Ram
Jan 1, 1979·The American Journal of Chinese Medicine·V Petkov
Apr 3, 1976·British Medical Journal·H Saarimaa
Apr 1, 1972·British Journal of Pharmacology·F KaticR D Lowe
Aug 1, 1965·The Journal of Pharmacy and Pharmacology·G Leszkovszky, L Tardos
Dec 1, 1966·The Journal of Pharmacy and Pharmacology·J Maj, R Langwinski
May 1, 1970·Life Sciences·N E AndénT Svensson
Mar 1, 1968·Circulation·E D FrohlichI H Page
Sep 1, 1966·The American Journal of Cardiology·F A Richards
Apr 1, 1951·The Journal of Experimental Medicine·S M FRIEDMANM NAKASHIMA

❮ Previous
Next ❯

Citations

Mar 1, 1994·Cardiovascular Drugs and Therapy·P ErnsbergerM O Christen
Jan 1, 1985·General Pharmacology·J I DrayerP P Frankfort
Jan 1, 1984·European Journal of Clinical Pharmacology·V Plänitz
Jan 1, 1987·European Journal of Clinical Pharmacology·J KapocsiE S Vizi
Jul 1, 1993·European Journal of Drug Metabolism and Pharmacokinetics·R AgbariaZ Ben-Zvi
May 11, 2001·Journal of Cardiovascular Pharmacology·P Ernsberger
Jan 1, 1983·Acta Medica Scandinavica·M Lilja
Sep 1, 1983·Journal of Autonomic Pharmacology·R K GoyalS C Verma
Jan 1, 1997·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·P ErnsbergerR J Koletsky
Dec 31, 1997·The American Journal of Physiology·P Ernsberger, M A Haxhiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.